• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

Obalon Therapeutics

MedTech 100 roundup: Another peak for the industry

January 25, 2021 By Sean Whooley

Medtech stocks have been on the rise in 2021, and the past week saw the trend continue with yet another all-time best mark. MassDevice‘s MedTech 100 index reached 107.4 points on Jan. 20, topping the all-time best of 106.81 points set on Jan. 8. That mark represents a 16% jump from the pre-pandemic high of 92.32 […]

Filed Under: Business/Financial News, Featured, MassDevice Earnings Roundup, Mergers & Acquisitions, Wall Street Beat Tagged With: Abbott, Amazon, Bardy Diagnostics, Boston Scientific, Cardiva Medical Inc., coronavirus, COVID-19, COVID-19 vaccine, GE Healthcare, Haemonetics, Hillrom, Intuitive Surgical, Joe Biden, MedTech 100 Index, Mesa Biotech, Obalon Therapeutics, Philips, Preventice, ReShape Lifesciences, Thermo Fisher Scientific

Obalon Therapeutics’ stock skyrockets after announcing ReShape Lifesciences merger

January 20, 2021 By Brian Buntz

Shares of intragastric balloon maker Obalon Therapeutics (NSDQ:OBLN) jumped as high as $10.71 today, or 568%, after the company announced a merger with ReShape Lifesciences (OTCMKTS:RSLS).  The San Diego-based company’s stock eventually closed at $9.52 per share, up 491%. Obalon’s stock had closed at $1.61 yesterday.  ReShape Lifesciences also saw a substantial jump in its stock price. […]

Filed Under: Business/Financial News, Featured, Mergers & Acquisitions Tagged With: Lap-Band, metabolic disease, Obalon Therapeutics, obesity, ReShape, ReShapeVest

Neuronetics, Obalon Therapeutics get PPP loans

April 28, 2020 By Sean Whooley

Neuronetics (NSDQ:STIM) and Obalon Therapeutics (NSDQ:OBLN) are the latest companies to announce that they entered into loans under the Paycheck Protection Program (PPP). The U.S. Small Business Association administers the PPP as part of the Coronavirus Aid, Relief and Economic Security (CARES) Act. Under the PPP, 75% of the loan proceeds must be used for payroll purposes, […]

Filed Under: Business/Financial News, Funding Roundup, Neurological, Neuromodulation/Neurostimulation, Weight loss Tagged With: coronavirus, COVID-19, Neuronetics, Obalon Therapeutics

Obalon to raise less from stock purchasing agreement

February 10, 2020 By Sean Whooley

Obalon Therapeutics (NSDQ:OBLN) announced that it entered into a new purchase agreement with Lincoln Park Capital Fund that will see a previously agreed purchase of $20 million of Obalon’s common stock drop to $15 million. The new purchase agreement between the two companies is replacing the existing deal from Dec. 27, 2018. The previous agreement has […]

Filed Under: Business/Financial News, Featured, Funding Roundup, Weight loss Tagged With: Lincoln Park Capital, Obalon Therapeutics

Obalon treats first patient at weight loss clinic

October 28, 2019 By Sean Whooley

Obalon Therapeutics (NSDQ:OBLN) said last week that it treated the first patients at its company-owned Obalon Center for Weight Loss in San Diego. The San Diego-based company produces an FDA-approved swallowable, gas-filled intra-gastric balloon for non-surgical weight loss. Obalon said the new center is staffed with physicians specializing in weight loss, along with nutritional counselors and […]

Filed Under: Business/Financial News, Weight loss Tagged With: Obalon Therapeutics

Obalon pays off its long-term debt

October 4, 2019 By Sean Whooley

Obalon Therapeutics (NSDQ:OBLN) said yesterady that it retired the remaining $5 million of its long-term debt facility with Pacific Western Bank. The San Diego-based company, which produces an FDA-approved swallowable, gas-filled intra-gastric balloon for weight loss, had previously cut its debt to Pacific Western Bank from $20 milllion to the remaining $5 million in July, while […]

Filed Under: Business/Financial News, Featured, News Well, Wall Street Beat, Weight loss Tagged With: Obalon Therapeutics

Innoblative taps ex-Lumicell chief Londy for CEO | Personnel Moves, Sept. 13, 2019

September 13, 2019 By Brad Perriello

Innoblative Designs last week named former Lumicell chief executive Kelly Londy as its new CEO. Apart from her two-year stint at the Lumicell helm, Londy was COO at Accuray (NSDQ:ARAY) and worked at GE Healthcare and Philips Healthcare. “Innoblative’s Sira RF ablation device offers unique capabilities that address shortcomings in the current advanced energy surgical market,” […]

Filed Under: Business/Financial News, Featured Tagged With: Alpha Tau Medical, Cala Health, Genetesis, Innoblative Designs, IRRAS, MiMedx Group Inc., Obalon Therapeutics, Orchestra BioMed, Ozop Surgical, Personnel Moves, Shine Medical Technologies

Obalon prices $15m offering

August 2, 2019 By Nancy Crotti

Obalon Therapeutics (NSDQ:OBLN) today priced a stock offering worth $15 million, with proceeds pegged to  finance its pivot to retail. The Carlsbad, Calif.-based company said it plans to float roughly 2.02 million shares of common stock together with warrants for 1.5 million shares of common stock and 1.74 million pre-funded warrants, each exercisable for one […]

Filed Under: Blog, Business/Financial News, Featured, Funding Roundup, Wall Street Beat Tagged With: Obalon Therapeutics

Obalon slashes debt, raises $9m for weight loss balloon

July 10, 2019 By Brad Perriello

Obalon Therapeutics (NSDQ:OBLN) said today that it slashed its debt load and added nearly $9 million to its coffers as it pivots toward a retail strategy. In April the Carlsbad, Calif.-based company, which makes a gas-filled balloon designed to treat obesity, revealed plans to lay off 50% of its employees, including all of its direct sales force, as it […]

Filed Under: Featured, Funding Roundup, Wall Street Beat, Weight loss Tagged With: Obalon Therapeutics

Obalon readies $17m offering for retail pivot

June 24, 2019 By Brad Perriello

Obalon Therapeutics (NSDQ:OBLN) last week registered a stock offering worth more than $17 million that it plans to use to finance its pivot to retail. In April the Carlsbad, Calif.-based company, which makes a gas-filled balloon designed to treat obesity, revealed plans to lay off 50% of its employees, including all of its direct sales force, in a […]

Filed Under: Clinical Trials, Featured, Funding Roundup, Wall Street Beat, Weight loss Tagged With: Obalon Therapeutics

Tevosol taps Organ Recovery Systems vet Mills for CEO | Personnel Moves, June 17, 2019

June 17, 2019 By Brad Perriello

Tevosol said it named Organ Recovery Systems veteran Ron Mills to be its new CEO. “Ron knows our technology and our market,” co-founder & CSO Dr. Darren Freed said in prepared remarks. “He brings a wealth of relevant experience to our team and adds a spark of creativity to drive the next exciting stage of […]

Filed Under: Business/Financial News Tagged With: Amplifon, electroCore, Golden Meditech Holdings Ltd., MediWound, Obalon Therapeutics, Personnel Moves, Repro Med Systems, Sanara, sciton, Tevosol, Zimmer Biomet

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Go to Next Page »

Primary Sidebar

DeviceTalks Weekly

May 20, 2022
DeviceTalks Boston Post-Game – Editors’ Top Moments, Insulet’s Eric Benjamin on future of Omnipod 5
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS